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Introduction
The mammalian cell cycle is controlled at the transcriptional level 
by the E2F family of transcription factors. E2F activity is repressed 
through binding to pocket proteins, a family that includes the retino-
blastoma tumor suppressor protein (pRb) as well as the related 
p107 and p130 proteins (Macaluso et al., 2006). The cell imple-
ments a signaling cascade whereby growth factors override the re-
pressive action of pocket proteins by activating Cdks. This leads to 
the activation of E2F target genes and allows progression through 
the G1–S phase transition. Under growth-repressive conditions, 
such as those occurring in the absence of mitogens, repressor E2Fs 
replace activator E2Fs on the promoters of target genes, in some 
cases recruiting pocket proteins and associated corepressors, which 
silences expression of these genes and promotes quiescence 
(Takahashi et al., 2000; Cam et al., 2004; Balciunaite et al., 2005).
Pocket proteins repress transcription by recruiting enzymatic 
complexes that modify the chromatin environment. The list of 
repressor proteins recruited by the pRb family includes histone 
deacetylases and polycomb group (PcG) repressor complex 2, 
although direct evidence for a specifi  c role for PcG repressor 
complex 2 (PRC2) in pRb-mediated transcriptional repression 
is lacking (Huang et al., 1991; Qian et al., 1993; Kuzmichev et al., 
2002; Benevolenskaya et al., 2005; Bracken et al., 2006). Multi-
subunit PcG complexes are essential for maintaining proper 
expression of homeotic genes in Drosophila melanogaster and 
generally function as transcriptional repressors (Orlando, 2003; 
Ringrose and Paro, 2004). The repressive action of PRC2 re-
quires its Ezh2 component, a histone methyltransferase (HMTase) 
that methylates lysine 27 of histone H3 (H3K27), which has 
been shown to facilitate the recruitment of the PRC1 complex 
and subsequent repression. In higher eukaryotes, the function of 
multiple subunits of the PRC2 complex, including Suz12 and 
Ezh2, is essential for the establishment of H3K27 methylation, em-
bryonic development, and cellular proliferation (Faust et al., 
1998; O’Carroll et al., 2001; Erhardt et al., 2003; Pasini et al., 
2004). Recently, it has been shown by chromatin immuno-
precipitation (ChIP)–on-chip that PRC2 promotes transcriptional 
silencing of many regulators of cell fate, development, and differ-
entiation, and that this repression is progressively lifted as differ-
entiation proceeds (Bracken et al., 2006; Lee et al., 2006). This 
regulatory mechanism is also relevant to muscle differentiation, 
wherein Ezh2 activity and the presence of the H3K27Me3 indicate 
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a correlation with repression of muscle differentiation genes in 
myoblasts (Caretti et al., 2004). Although repression by PcG 
complexes plays an essential role in proliferation and development, 
the mechanisms underlying their recruitment and eventual dis-
sociation from specifi  c target genes remain largely unknown.
A hallmark of vertebrate differentiation is irreversible cell 
cycle exit, wherein cells become refractory to subsequent mitogen 
stimulation and differentiated skeletal muscle cells never resume 
proliferation (Molkentin and Olson, 1996). Although reversible 
cell cycle exit has been studied extensively and the role of pocket 
proteins is rather well understood (Zhang et al., 2000; Sage et al., 
2003; Cam et al., 2004; Korenjak et al., 2004; Balciunaite et al., 
2005), how an irreversibly arrested state is established and main-
tained is less clear. The pocket proteins have been the focus of 
intense scrutiny and many studies have implicated pRb in the cell 
cycle blockade of muscle cells. pRb knockout mice die in utero 
before the development of skeletal muscle. However, the skeletal 
muscles of animals rescued from embryonic death by hypo-
morphic expression of an RB minigene or by tetraploid aggregation 
show signs of apoptosis, improper cell cycle exit, and endo-
reduplication (Zacksenhaus et al., 1996; Wu et al., 2003). Mice defi  -
cient in either p107 or p130 do not exhibit detectable muscle 
phenotypes and, although mice defi  cient in both p107 and p130 
die at birth, they also lack a discernible muscle phenotype, 
which suggests that pRb is the sole pocket protein involved in 
the control of myogenic differentiation (Cobrinik et al., 1996). 
However, in spite of the information obtained from germ-line 
knockout studies, a defi  nitive model for the role of each pocket 
protein in regulating myogenesis has not emerged, largely owing 
to the fact that compensatory mechanisms confound the analysis 
of contributions from individual pRb family members.
Here, we investigate the mechanisms underlying mainte-
nance of cell cycle arrest in differentiated skeletal muscle cells. 
To circumvent complications arising from cell cycle alterations, 
we suppressed pRb expression in fully differentiated myotubes 
using RNAi. We have made the notable fi  nding that pRb is not 
only important for initial cell cycle exit at the onset of myo-
genesis but also for the maintenance of this arrest in mature 
myotubes. Depletion of pRb causes both C2C12 and primary myo-
tubes to resume proliferation and complete S phase. Importantly, 
we also discovered a role for p107 and p130 in preventing progres-
sion of pRb-depleted myotubes into M phase. Our studies show 
that H3K27Me3 marks promoters of cell cycle genes, which 
strongly coincides with pRb-mediated repression, cell cycle exit, 
and maintenance of terminal differentiation. However, we also 
identifi  ed a distinct mechanism for the cyclin D1 (Ccnd1) gene, 
which acquires the H3K27Me3 mark in a pRb-independent 
but PcG-  dependent manner. We describe a transcriptional 
regulatory framework that explains, at least in part, the irrevers-
ibility of cell cycle exit in muscle cells.
Results
Cell cycle reentry after impairment of 
pRb function in differentiated muscle
The role of pRb in skeletal muscle differentiation and cell cycle 
exit has been studied using several models that include functional 
inactivation with viral oncoproteins, germ line ablation, and con-
ditional excision. It is likely that functional compensation by 
p107 and p130 and the pocket protein–independent effects of 
oncoproteins have obscured the individual contribution of each 
pocket protein to myogenesis and cell cycle arrest. To address 
this issue, we performed acute, RNAi-mediated suppression of 
pocket proteins in growing and terminally differentiated C2C12 
mouse myotubes. The C2C12 system represents a well-established 
in vitro differentiation model, and our work previously indicated 
that the gene expression program activated during C2C12 myo-
genic differentiation closely resembles the one observed in pri-
mary myoblasts undergoing differentiation (Blais et al., 2005).
First, we tested the effi  cacy of siRNAs that target each 
individual pocket protein. We found that pRb is required for 
skeletal myogenesis and initiation of cell cycle exit because its 
ablation in myoblasts impaired their differentiation and was ac-
companied by their failure to cease proliferation (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200705051/DC1). 
These results are consistent with previous studies using knock-
out cells. Importantly, the block to differentiation specifi  cally 
resulted from pRb knockdown and did not occur after ablation 
of the other two pocket proteins. This fi  nding strongly supports 
the notion that pRb is uniquely required to promote cell cycle 
arrest and myogenic differentiation.
Next, we acutely depleted each pocket protein in fully dif-
ferentiated cells by transfecting siRNAs into myotubes. Our ex-
periments indicated that myotubes were fully differentiated after 
4 d in differentiation medium (Fig. S1 B). Delivery of each 
siRNA specifi  cally suppressed expression of its target and we 
achieved equally dramatic reductions in the level of each protein, 
which could be detected as early as 18–24 h after transfection 
(Fig. 1, A and B; Fig. S1 C; and not depicted). Importantly, we 
tested additional siRNAs targeting pRb and p130 and showed 
that each siRNA behaved with comparable specifi  city and effi  -
ciency (Fig. S2 A, available at http://www.jcb.org/cgi/content/
full/jcb.200705051/DC1). We determined whether pRb ablation 
would affect the quiescent state of myotubes. Cell cycle exit is 
a prerequisite for myogenic differentiation and is thought to be 
irreversible. To this end, we examined BrdU incorporation after 
transfection of siRNAs targeting each pocket protein and deter-
mined whether cell cycle reentry occurred in differentiated 
muscle cells. Remarkably, myotubes treated with siRNAs targeting 
pRb reentered S phase, in sharp contrast with nonspecifi  c control 
duplexes (Fig. 1 C). On average, >60% of fully differentiated 
muscle cells reentered the cell cycle, which attests to the robustness 
of the phenotype (Fig. 1 D). S phase reentry was not enhanced 
by concomitant growth factor stimulation (unpublished data), 
presumably because pRb is itself the ultimate target of growth 
factors through Cdk-mediated phosphorylation. To ensure that 
this effect was specifi  c for pRb and to rule out off-target effects, 
we tested multiple distinct siRNAs (Fig. S2 B) and obtained 
identical results. To test the possibility that cell cycle reentry after 
pRb knockdown was restricted to C2C12 cells, an established 
cell line, we isolated primary myoblasts from the skeletal mus-
cle of newborn mice, subjected them to a differentiation protocol, 
and transfected the resulting myotubes. Although the transfection 
effi  ciency of primary myotubes was lower than C2C12   myotubes PRB AND IRREVERSIBLE CELL CYCLE ARREST • BLAIS ET AL. 1401
( 30 vs. 80%), the results were qualitatively similar (Fig. 1 E); 
primary muscle cells also require functional pRb to remain ter-
minally arrested. Importantly, this result further confi  rms the va-
lidity of using the C2C12 model in our experiments.
We tested the possibility that suppression of p107 or p130 
expression could similarly promote cell cycle reentry in differ-
entiated myotubes. In striking contrast to cells depleted of pRb, 
we observed no increase in BrdU-positive myotubes lacking ei-
ther p107 or p130 (Fig. 1, C and D). Moreover, the combined 
loss of both p107 and p130 also failed to induce cell cycle re-
entry. We note that p107 is not expressed in myotubes or differ-
entiated muscle (Fig. S1 A) but it is signifi  cantly induced after 
knockdown of pRb (Fig. 1, A and B), a phenomenon that has 
also been observed by others (Schneider et al., 1994; Novitch 
et al., 1996) presumably because it is directly repressed by pRb 
(Hurford et al., 1997). p130 levels also increased moderately 
after pRb knockdown (Fig. 1, A and B). However, the dramatic 
elevation in p107 and p130 levels is not suffi  cient to bypass a 
requirement for pRb in suppressing cell cycle reentry and is 
consistent with the absence of inappropriate proliferation in 
myotubes lacking p107 and p130.
Because p107 and p130 also repress E2F activity and po-
tentially compensate for pRb loss, we simultaneously suppressed 
both pRb and p107 or p130 in differentiated muscle cells. We rea-
soned that if p107 and/or p130 could compensate for diminished 
levels of pRb, then cell cycle reentry would be enhanced by 
depleting a second pocket protein in addition to pRb. How-
ever, we did not observe a further increase in the proportion 
of BrdU-positive cells, irrespective of which proteins were de-
pleted (Fig. 1, C and D). Furthermore, depleting all three pocket 
proteins did not further expand the proportion of cells in S phase 
(unpublished data). These data strongly suggest that the mainte-
nance of cell cycle arrest, and thus the differentiated state, criti-
cally depends on pRb but not the other two pocket proteins.
Interestingly, however, we noticed that myotubes depleted 
of both pRb and a second pocket protein frequently exhibit 
pinching between nuclei, in some cases causing entry into mito-
sis and apparent myotube fragmentation (Fig. S3, available at 
http://www.jcb.org/cgi/content/full/jcb.200705051/DC1). These 
data suggest that p107 and p130 play a fail-safe role of blocking 
cells at the G2/M boundary that have progressed through S phase. 
Loss of this G2/M “checkpoint” results in further progression of 
Figure 1.  pRb depletion leads to cell cycle reentry in terminally differentiated muscle cells. (A) RT-PCR detection of pocket protein mRNA expression 48 h 
after transfection of C2C12 myotubes with siRNA duplexes. (B) Western blot detection of each pocket protein indicates the extent of knockdown achieved 
in a typical experiment. (C) Immunoﬂ  uorescent detection of BrdU incorporation (green) and MHC expression (red) in differentiated C2C12 myotubes after 
transfection with a nonspeciﬁ  c siRNA duplex or duplexes targeting various pocket protein combinations. (D) Histogram representing the proportion of 
C2C12 myotubes with at least one BrdU
+ nucleus after transfection with the indicated siRNA. Error bars indicate SD of three independent experiments. 
(E) Immunoﬂ  uorescent detection of BrdU incorporation (red) and MHC expression (green) in primary myotubes after transfection with a nonspeciﬁ  c siRNA 
duplex or a duplex targeting pRb. Bars, 100 μm. JCB • VOLUME 179 • NUMBER 7 • 2007  1402
differentiated muscle cells into mitosis. This function is only 
uncovered in cells that have simultaneously lost pRb, which fur-
ther emphasizes the utility of our acute knockdown approach.
Cells depleted of pocket proteins exhibit 
alterations in genome-wide expression 
proﬁ  les
We have conclusively shown that myotubes reenter the cell 
cycle after pRb loss, prompting us to determine whether this 
event is associated with changes at the gene expression level. 
We performed genome-wide expression profi  ling on myotubes 
treated with pRb-specifi  c siRNA and observed widespread de-
repression of cell cycle genes (Fig. 2 A and Table S1, available at 
http://www.jcb.org/cgi/content/full/jcb.200705051/DC1). As ex-
pected, because its expression is barely detectable in myotubes, 
p107 suppression had very mild effects on the gene expression 
profi  le. In addition, we observed remarkably few differences 
after suppressing p130 or p107 and p130 (Fig. 2 A; Table S1, 
and not depicted), despite the fact that p130 is expressed at high 
levels in myotubes and was suppressed to an extent comparable 
to pRb (Fig. 1, A and B).
We used gene ontology to analyze the changes associated 
with pRb loss and found that the majority of derepressed genes 
are involved in cell cycle control, DNA replication, segregation, 
cytokinesis, and the response to DNA damage. The vast majority 
(74%) of these pRb-repressed genes exhibit diminished ex-
pression in differentiated cells as compared with proliferating 
myoblasts (Fig. 2 B, top left quadrant). Finally, expression profi  ling 
of cells transfected with a second siRNA against pRb showed nearly 
interchangeable profi  les with the fi  rst dataset (Fig. S4, available 
at http://www.jcb.org/cgi/content/full/jcb.200705051/DC1), 
which suggests that the derepression of cell cycle genes we ob-
served is not caused by off-target effects.
We inspected the proximal promoters of derepressed genes 
and found that a large portion are known or predicted E2F targets 
as was expected (unpublished data). We then performed ChIP-
on-chip with an antibody against E2F4 because it is the pre-
domi  nant “repressor E2F” family member expressed in myotubes 
(unpublished data). We confi  rmed that many genes derepressed 
after the loss of pRb are bound by E2F4 in differentiated muscle 
cells. This is associated with a p-value of 9.4 × 10
−26 by hyper-
geometric distribution (Fig. 2 C), which indicates that there is a 
very strong association between derepression after pRb ablation 
and regulation by E2F4. Furthermore, E2F4 target genes are in-
duced 3.1-fold after pRb knockdown on average, whereas genes 
that are not bound by E2F4 are not signifi  cantly induced (1.2-
fold; P = 4 × 10
−47 for t test; Fig. 2 C). We have so far been unable 
to knockdown the expression of E2F4 and thus have not been 
able to further investigate the involvement of E2F4 in pRb-
mediated repression. Together, these data suggest that depletion 
of pRb causes cell cycle reentry of terminally arrested myotubes 
through widespread deregulation of E2F target gene expression.
The expression of 62 genes diminished signifi  cantly upon 
loss of pRb. Interestingly, these genes, which include Mef2c, 
Ankrd2, Csrp3, and various myosin isoforms, are strongly as-
sociated with muscle development and function, and many of 
them are known or predicted targets of the muscle regulatory 
factors MyoD, myogenin, or Mef2c (Fig. 2, A and B, bottom right 
quadrant; Blais et al., 2005). These genes also have a strong ten-
dency to be induced during muscle differentiation (6.5-fold induc-
tion during myogenesis on average as compared with no change 
for the mean of all other genes; P = 4 × 10
−95 for t test; Fig. 2 B).
Perhaps our most striking observation was that expression 
of myogenic differentiation genes decreases subsequently to the 
establishment of a terminally differentiated state in the absence 
of pRb. That is, because our experiments were performed with 
isolated myotubes that had already differentiated before pRb 
depletion, our conclusions are not confounded by the block to 
differentiation that is encountered by myoblasts that have lost pRb 
(Fig. S1). These studies strongly suggest that loss of pRb promotes 
“dedifferentiation” of myotubes, returning them to a proliferative, 
myoblast-like state (Cobrinik et al., 1996; Zacksenhaus et al., 
1996; Wu et al., 2003). Thus, pRb function is essential not only for 
the establishment of cell cycle arrest during myogenic differenti-
ation but also for its maintenance.
A mechanism for permanent cell cycle exit: 
histone H3K27 methylation
We postulated that pRb-mediated recruitment of chromatin-
modifying activities and subsequent modifi  cation of chromatin 
could establish a stable, repressive mark on such promoters and 
lead to the heterochromatinization of its target genes. To test 
this hypothesis, we performed a systematic screen for 10 different 
histone tail modifi  cations associated with both transcriptionally 
active and repressed chromatin in growing and differentiated 
muscle cells. Our goal was to determine which chromatin modi-
fi  cations are most robustly associated with irreversible cell cycle 
arrest during myogenic differentiation. A complete analysis of 
the results of this screen will be described elsewhere (unpub-
lished data). Here, we focused exclusively on those genes that 
were transcriptionally derepressed in myotubes depleted of pRb. 
We found that one particular mark, di- and trimethylation of 
histone H3K27 (here we do not distinguish between the di- and 
trimethylated state and refer to this modifi  cation as H3K27Me2/3), 
increased most signifi  cantly on a large number of genes that were 
both transcriptionally silenced during myogenic differentiation and 
derepressed after pRb ablation (Fig. 3 A and Table S2, available 
at http://www.jcb.org/cgi/content/full/jcb.200705051/DC1). 
H3K27Me2/3 levels were elevated 2–13-fold in myotubes when 
compared with growing myoblasts as assessed by quantitative 
real-time PCR (qChIP; Fig. 3 B). In contrast, other marks known 
to be associated with repressed chromatin, including trimethylation 
of histone H3K9 and histone H4K20, exhibited little or no dif-
ference on 20 genes that we surveyed during the transition from 
myoblasts to myotubes. The Mef2c promoter displayed the op-
posite pattern: H3K27Me2/3 levels dramatically decreased as cells 
differentiated into myotubes (Fig. 3, A and B). These Mef2c meth-
ylation data are consistent with previous results, which indicates 
that certain muscle-specifi  c genes are repressed via trimethylation 
of H3K27 specifi  cally in myoblasts (Caretti et al., 2004). Other 
genes, including stably silenced homeotic control genes, exhibited 
no change in H3K27Me2/3 levels (Fig. 3, A and C; and not de-
picted), which indicates that changes in H3K27 methylation levels 
were highly promoter specifi  c.PRB AND IRREVERSIBLE CELL CYCLE ARREST • BLAIS ET AL. 1403
We also determined whether the increase in signal detected 
in Fig. 3 (A and B) was caused by an increase in di- and/or tri-
methylation of H3K27 in ChIP assays using antibodies specifi  c for 
both forms of H3K27. As shown in Figs. 3 C and S5 A (avail-
able at http://www.jcb.org/cgi/content/full/jcb.200705051/DC1), 
the majority of pRb target genes display marked increases in both 
di- and trimethyl H3K27. We note that although these histone 
marks increase or decrease in abundance during myogenic differ-
entiation, the global levels of nucleosome occupancy at the tested 
loci remain relatively constant (Fig. 3 C), which suggests that his-
tone modifi  cation rather than nucleosome loading or eviction 
is the primary mechanism explaining these fl  uctuations.
We examined the temporal appearance of the H3K27Me2/3 
mark during the course of differentiation and found that it remains 
stable or gradually rises during the early stages of myogenesis. 
Interestingly, the mark dramatically appears between 2 and 4 d 
after induction of differentiation, reaching maximal levels after 
4 d (Fig. 3 D). These data suggest that the acquisition of this mark 
is a relatively late event in the differentiation process.
We verifi  ed that the appearance of the H3K27Me2/3 mark 
during differentiation is not exclusive to C2C12 myoblasts be-
cause the mark is also acquired as primary myoblasts differentiate 
(Fig. 3 E). Here, quantitative ChIP assays were per  formed using 
primary myoblasts that were obtained from mouse muscle tissue 
and maintained in the proliferative state or induced to differentiate. 
Fig. 3 E clearly demonstrates that the H3K27Me2/3 ChIP signal 
signifi  cantly and reproducibly increases (P < 0.03 by t test) at 
several pRb target genes during myogenic differentiation of 
Figure 2.  Loss of pRb leads to derepression of cell cycle control genes. (A) RT-PCR detection of pocket protein, cell cycle, and muscle function gene expres-
sion 48 h after suppression of pocket protein expression in C2C12 myotubes. (B) Scatter plot representing the change in gene expression in C2C12 myo-
tubes upon knockdown of pRb as a function of the gene expression changes during the normal course of myogenic differentiation. Each spot represents 
one measurement with one microarray probe. MT, untransfected myotubes; GM, untransfected growing myoblasts; NS, myotubes transfected with a non-
speciﬁ  c siRNA duplex; pRb, myotubes transfected with the pRb-speciﬁ  c duplex. All data points represent the combination of three independent experiments. 
(C) Scatter plot representing the change in gene expression in myotubes after pRb knockdown as a function of the degree of binding of E2F4 in a ChIP-
on-chip microarray experiment performed in C2C12 myotubes. The binding ratio serves as an indirect measure of the strength of binding of E2F4 to its 
target genes; a cut-off corresponding to a twofold enrichment was used.JCB • VOLUME 179 • NUMBER 7 • 2007  1404
primary myoblasts, whereas control genes are not signifi  cantly 
affected. The mean effect is twofold for pRb-regulated genes. 
This increase in H3K27Me2/3 was somewhat lower than in C2C12 
cells, most likely because primary myoblasts tend to spontaneously 
exit the cell cycle and differentiate even when maintained in 
growth medium at relatively low confl  uence, as we have done here 
(unpublished data).
The role of pRb in establishing the 
H3K27Me3 mark
We sought to establish a causal relationship between pRb function 
and H3K27 methylation at cell cycle control genes. If methylation 
of H3K27 is responsible for maintaining these genes in an irrevers-
ibly repressed state and pRb is specifi  cally required to promote 
and maintain this mark, then pRb depletion but not stimulation 
of myotubes with mitogens should result in the disappearance 
of this mark and thereby lead to their reexpression. We tested 
this idea by performing ChIP assays on fully differentiated myo-
tubes treated with serum or transfected with pRb-specifi  c or 
control siRNAs.
Differentiated muscle cells are refractory to mitogenic stimu-
lation, and cell cycle control genes remain silent upon such 
stimulation (Fig. 4 A). As shown in Fig. 4 B, the extent of 
H3K27 methylation of cell cycle regulatory genes is unaffected 
Figure 3.  H3K27 trimethylation of cell cycle gene promoters during myogenic differentiation. (A) qChIP on chromatin from either C2C12 myoblasts or 
myotubes using antibodies that recognize H3K27Me2/3, H3K9Me3, and H3Ac. A scatter plot indicates the fraction of input DNA immunoprecipitated 
from each state. Values obtained with the H3Ac antibody were divided by 10 to ﬁ  t on the same plot as the other two datasets. Results represent the mean 
of at least three independent experiments. (B) Histogram representing the H3K27Me3 signal from A. The Hoxa5 and Mef2c genes served as speciﬁ  city 
controls. Error bars indicate SD of three independent experiments. (C) ChIP assay performed in C2C12 myoblasts and myotubes using antibodies against 
histone H3, H3K27Me2 or H3K27Me3, or rabbit IgG. (D) ChIP assay performed on cells at different times after induction of differentiation. The 96-h Mt 
sample represents pure myotubes, whereas the samples labeled 96 h and earlier time points represent the mixed cell population before separation of myo-
tubes from reserve cells. (E) Quantitative ChIP assays for H3K27Me2/3 performed in primary myoblasts and matched myotubes. The mean of four ChIP as-
says and standard errors are shown. The ratio of H3K27Me2/3 signal in myotubes over that in myoblasts is indicated in red below each gene name. 
Asterisks indicate an H3K27Me2/3 signal signiﬁ  cantly higher in myotubes than in myoblasts; P < 0.03 by t test. The double asterisk indicates an 
H3K27Me2/3 signal signiﬁ  cantly lower in myotubes than in myoblasts; P < 0.001 by t test. PRB AND IRREVERSIBLE CELL CYCLE ARREST • BLAIS ET AL. 1405
Figure 4.  Trimethylation of H3K27 is insensitive to mitogenic stimulation and does not occur during reversible, mitogen starvation–induced quiescence. 
(A) RT-PCR assay of gene expression in C2C12 myoblasts and myotubes or myotubes treated with high serum concentrations for 24 h (Mt + GM). (B) ChIP 
assay performed on samples from cells analyzed in A. The input control corresponds to 0.4% of the amount used per immunoprecipitation. The Hoxa5 
gene is shown as a control for efﬁ  ciency of immunoprecipitation by the anti-H3K9Me3 antibody. (C) MEFs were harvested during asynchronous growth or 
after 3 d of starvation in serum-free medium. RNA was extracted and cell cycle gene expression was assessed by RT-PCR. (D) ChIP assays performed on 
cross-linked cells treated and processed in parallel with those indicated in C.JCB • VOLUME 179 • NUMBER 7 • 2007  1406
by   treatment of mature myotubes with high concentrations of 
mitogens, which indicates that once established this histone 
mark is stable and may thus contribute to the permanent nature 
of the cell cycle exit. In addition, the degree of histone H3 acet-
ylation is also unchanged after mitogen treatment, which is con-
sistent with the observation that these genes are not reexpressed.
Furthermore, if H3K27 methylation is involved in terminal 
transcriptional silencing of pRb target genes, then this histone 
mark should be specifi  c to instances of irreversible cell cycle 
arrest. We tested this idea by performing analogous experiments 
using mouse embryonic fi  broblasts (MEFs) that had been brought 
to quiescence through mitogen deprivation. It is known that this 
state is fully reversed upon mitogen stimulation (Pardee, 1974). 
As expected, the cell cycle control genes we examined previously 
are repressed when MEFs are rendered quiescent (Fig. 4 C), but 
this silencing is not accompanied by the appearance of the 
H3K27 di- or trimethylation marks, despite the fact that histone 
H3 acetylation levels are markedly decreased (Fig. 4 D). These 
results indicate that trimethylation of H3K27 at pRb target 
genes is not a generic mark of nonproliferative cells. Instead, 
methylation of these targets is context dependent and specifi  c to 
permanently arrested cells.
Next, we examined the impact of pRb depletion on H3K27 
methylation by performing ChIP on chromatin from myotubes 
depleted of pRb. In striking contrast with serum addition, pRb 
knockdown resulted in the marked diminution of the H3K27Me2/3 
signal at several genes compared with controls (Fig. 5 A and 
Table S2). This coincides with derepression of these genes under 
the same conditions (Fig. 2 A and Table S1). Notably, although 
p130 could also be depleted with comparable effi  ciency (Fig. 1), 
its loss did not lead to a reduction in H3K27Me2/3 signal at 
these genes (Fig. 5 B). Further, other genes, including Ccnd1, 
whose expression was not affected by ablation of pRb, did not 
exhibit any signifi  cant differences in H3K27Me2/3 levels after 
pRb knockdown (Fig. 5 A, controls; P = 0.001 by one-tailed t test). 
Importantly, these fi  ndings rule out the possibility that histone 
replacement during DNA replication (induced by pRb depletion) 
is responsible for the decrease in the H3K27Me2/3 signal. Interest-
ingly, depletion of pRb did not affect histone H3 acetylation 
levels at the promoters of derepressed genes (Fig. 5 C).
We have thus shown that pRb is essential for the mainte-
nance of the H3K27Me2/3 mark at the promoter of cell cycle 
regulatory genes in terminally arrested muscle cells. Ablation of 
pRb causes the loss of trimethylation at H3K27 and ultimately 
leads to reexpression, causing the cells to reenter the cell cycle 
(Fig. 6 B).
Role of PcG repressor complex
We sought to determine if pRb-regulated genes recruit PcG 
complexes known to be involved in H3K27 methylation and 
subsequent gene silencing. ChIP assays using antibodies di-
rected toward a PRC1 component, Bmi-1, and two core compo-
nents of PRC2, Suz12 and Ezh2, failed to reveal convincing 
binding to pRb target genes during differentiation, although we 
surveyed up to  3 kb upstream of several genes and showed 
that Ezh2 is expressed in myotubes (Figs. 5 D and S5 B; and not 
depicted). In contrast, recruitment of these proteins at homeotic 
control genes (Hoxd10 and Hoxb8) was readily detected ir-
respective of differentiation status (Fig. 5 D and not depicted).
In addition to pRb target genes, we also examined the 
Ccnd1 gene because it plays a key role in regulating cell cycle 
progression in response to growth factors. Its silencing during 
myogenesis is accompanied by trimethylation of H3K27 but is 
pRb independent (Fig. 5 A). Indeed, Ccnd1 exhibits the most 
dramatic increase in methylation during differentiation and is 
among the most strongly repressed cell cycle genes (Fig. 3, C–E; 
Fig. 4, A and B; and Table S1). Interestingly, we found that the 
PRC2 and PRC1 complexes are recruited to the Ccnd1 promoter 
specifi  cally in myotubes (Fig. 5 D). Additionally, several other 
genes implicated in growth control or response to mitogens were 
also found to be silenced during myogenesis in a H3K27Me3-
associated, pRb-independent manner (Fig. S5 A and Table S1).
These data therefore suggest the existence of at least two 
distinct pathways toward repression of the cell cycle machinery 
in differentiated muscle cells: one group of genes is trimethyl-
ated on H3K27 and repressed via pRb, whereas a second group 
is repressed independently of pRb through a mechanism that 
likely involves PcG complexes (Fig. 6 B).
Discussion
Acute ablation of pocket proteins in 
differentiated myotubes
Our fi  ndings regarding a specifi  c requirement for pRb in cell 
cycle exit and myogenic differentiation are consistent with pre-
vious knockout studies as well as recent studies using condi-
tional ablation of RB in myoblasts in mice and cultured cells 
(Camarda et al., 2004; Huh et al., 2004). However, our acute 
depletion experiments allowed us to show defi  nitively that the 
combined loss of p107 and p130 has no effect on myogenic dif-
ferentiation. Our experiments are less likely to be complicated 
by the issue of compensation by pRb, which may have occurred 
in earlier germline knockout studies and confounded the analysis 
(Cobrinik et al., 1996). In contrast to earlier studies (Gu et al., 
1993; Endo and Nadal-Ginard, 1998), our use of RNAi has al-
lowed us to avoid the use of viral oncogenes, which are known 
to deregulate all three pocket proteins as well as a plethora of 
other cellular proteins, and has enabled us to perform more pre-
cise gene ablation experiments.
In contrast with a demonstrated role for pRb in differenti-
ation, the role for this protein in maintenance of terminal differ-
entiation is less clear. We discovered that pRb is also involved in 
maintaining the postmitotic state of differentiated muscle cells by 
suppressing the expression of cell cycle control genes. Importantly, 
these fi  ndings were obtained using both well-characterized C2C12 
myoblasts and myotubes prepared from primary myoblasts, which 
rules out the immortal nature of the cell line as the cause of cell 
cycle reentry. However, Camarda et al. (2004) and Huh et al. 
(2004) showed that conditional ablation of Rb in differentiated 
myotubes using viral transduction or muscle creatine kinase–
driven Cre expression produced no obvious cell cycle reentry 
and suggested that pRb is involved in the establishment but not 
maintenance of the differentiated state. Although we cannot 
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published recently, several important technical differences are 
noteworthy. First, differences may stem from the kinetics of knock-
down; i.e., we acutely ablated pRb from differentiated myotubes 
and knockdown occurred typically within 18 h after siRNA deliv-
ery. In contrast, other studies required a longer duration to achieve 
suppression of pRb. A second possibility is that Cre-mediated 
Figure 5.  pRb-dependent trimethylation of H3K27 at cell cycle gene promoters. (A) Histogram indicating H3K27Me2/3 levels in C2C12 myotubes trans-
fected with a nonspeciﬁ  c control or pRb-silencing siRNA. The ChIP signal intensity is reported as a fraction of the signal obtained in cells transfected with 
the nonspeciﬁ  c siRNA. (B and C) Histograms depicting H3K27Me2/3 (B) and H3Ac (C) levels in C2C12 myotubes transfected with siRNAs targeting p130 
or pRb or with a nonspeciﬁ  c control siRNA as indicated in A. Error bars represent SD of three independent experiments. (D) ChIP assay performed in 
C2C12 myoblasts and myotubes using antibodies directed against Suz12, Ezh2, and Bmi-1. Two regions of the Hoxd10 gene were surveyed to evaluate 
PRC binding. The results of two independent experiments are shown.JCB • VOLUME 179 • NUMBER 7 • 2007  1408
excision triggers or contributes to a checkpoint because Cre-
mediated recombination has been shown to suppress the growth 
of proliferating cells and elicits a DNA damage response in mam-
malian cells (Loonstra et al., 2001; Pfeifer et al., 2001; Silver and 
Livingston, 2001; Baba et al., 2005). This could conceivably 
prevent cell cycle reentry or survival of pRb-deleted myotubes. 
A third explanation derives from the extent to which pRb ex-
pression was suppressed. We note that our RNAi approach does 
not lead to a complete loss of pocket proteins but rather a strong 
decrease in their expression, possibly generating a hypomorphic 
phenotype. In such a scenario, pRb levels are lowered below the 
threshold necessary for blocking cell cycle progression but re-
main high enough to execute certain functions such as the pre-
vention of apoptosis. In this regard, it is interesting to note that 
conditional excision of RB alleles in muscle creatine kinase–
Cre–expressing myoblasts promotes apoptosis to some extent 
during the differentiation time course, and it is possible that this 
is a consequence of deregulated E2F1 function after pRb loss, 
which may not occur with our approach. In fact, massive induc-
tion of apoptosis after excision of RB in myotubes was also re-
ported by Camarda et al. (2004), prompting them to overexpress 
the antiapoptotic protein Bcl-2 to counteract this effect in at 
least some of their experiments. We note that Bcl-2 has been 
shown to exert antiproliferative effects in certain cell types and 
thus its enforced expression could have precluded cell cycle re-
entry in pRb-depleted myotubes (Vairo et al., 1996, 2000). Thus, 
the fact that apoptosis was provoked by depletion of pRb from 
myotubes confi  rms our conclusion regarding an essential role 
for pRb in maintaining their postmitotic state.
Remarkably, our depletion of pRb from myotubes not only 
led to reexpression of genes associated with proliferation but 
also dramatically reduced expression of genes involved in muscle 
development and function. Because we performed these experi-
ments with fully differentiated cells, it is clear that reduced 
Figure 6.  Model detailing pRb function in differentiated muscle. See text for details. PRB AND IRREVERSIBLE CELL CYCLE ARREST • BLAIS ET AL. 1409
expression of these genes is not simply a consequence of defec-
tive differentiation. Instead, the cells depleted of pRb exhibit 
the hallmarks of dedifferentiation. One model that could explain 
our data posits that pRb acts as a coactivator for the expression 
of muscle differentiation genes by cooperating with other tran-
scription factors that promote differentiation (Singh et al., 1995; 
Chen et al., 1996; Thomas et al., 2001). Moreover, our fi  ndings 
may also be consistent with a second model in which pRb en-
hances the activation of MyoD target genes by sequestering the 
histone deacetylase 1 repressor away from MyoD (Puri et al., 
2001). Our genome-wide studies have vastly extended the notion 
that pRb acts positively to maintain expression of muscle-specifi  c 
genes after terminal differentiation.
Reevaluating the role of pocket proteins: 
a model for irreversible cell cycle exit and 
maintenance of the differentiated state
Although p107 and p130 are highly related to pRb and clearly 
display highly overlapping biochemical activities, neither p107 
nor p130 mutations have been widely implicated in human cancer 
(Paggi et al., 1996; Dannenberg and te Riele, 2006; Wikenheiser-
Brokamp, 2006). This fi  nding has been ascribed to redundancy 
between pocket proteins as well as tissue-specifi  c requirements 
(Lee et al., 1996; Robanus-Maandag et al., 1998; Lee et al., 
2002; Dannenberg et al., 2004). We found that the function of 
p107 and p130 is not required for the establishment or the main-
tenance of cell cycle exit and that their absence does not lead to 
derepression of cell cycle control genes. This situation is unlike 
the one prevailing in fi  broblasts, where these pocket proteins are 
essential for the silencing of cell cycle genes during quiescence 
(Rayman et al., 2002; Balciunaite et al., 2005), and suggests 
that cell cycle arrest in differentiated muscle is mechanistically 
very different from that of other cell types. However, our data 
reveal a role for p107 and p130 in control over a G2/M check-
point that is uncovered only in the absence of pRb and provide 
a novel explanation for the role of p107 and p130 in the context 
of differentiation. A role for p130 in G2/M had been suggested 
previously (Mayol et al., 1995), which is a hypothesis we have 
experimentally substantiated here. Moreover, because this func-
tion is uncovered exclusively in cells that have simultaneously 
lost pRb, our fi  ndings could explain a long-standing conundrum 
in the fi  eld; namely, why pRb is a tumor suppressor with strong 
connections to human cancer, whereas mutations in the p107 
and p130 genes are not widely associated with tumors.
We propose that pRb acts fi  rst to uniquely promote myo-
genic differentiation and, subsequently, block cell cycle reentry 
and DNA replication in myotubes (Fig. 6 A). Cells that escape 
this barrier (if and only if pRb function is compromised) are 
likely to arrest in late S or G2 phase because a fail-safe mechanism 
that requires p107 or p130 blocks further cell cycle progression. 
Loss of this G2/M checkpoint results in further progression of 
differentiated muscle cells into mitosis.
A role for H3K27 methylation in 
maintenance of the differentiated state
We have found that trimethylation of H3K27 plays an unantici-
pated and widespread role in repressing expression of cell cycle 
genes during differentiation of C2C12 and primary myoblasts. 
Four characteristics indicate that it constitutes a chromatin mark 
essential for mediating the effect of pRb in the repression of these 
genes. First, the mark appears at the promoter of pRb-repressed 
genes specifi  cally during the differentiation of myotubes, which 
coincides with gene silencing. Second, the mark is erased after 
the loss of pRb in myotubes, which coincides with gene de-
repression. Third, trimethylation of H3K27 is not erased after 
treatment of myotubes with growth factors, paralleling the serum-
insensitive repression of these genes. Fourth, the H3K27Me3 mark 
appears to be specifi  c to irreversibly arrested myotubes and is 
not detected when genes are temporarily silenced during cellu-
lar quiescence.
Previous studies have implicated methylation of H3K9 in 
repressing certain cell cycle genes during myogenesis or quies-
cence (Nielsen et al., 2001; Ait-Si-Ali et al., 2004). Here, H3K27 
and H3K9 trimethylation have been more extensively examined 
during differentiation. We have confi  rmed that certain promoters 
(Bub1 and Mcm5) exhibit enhanced trimethylation of H3K9 dur-
ing myogenic differentiation but that the absolute levels of H3K9 
methylation at these loci are substantially lower than those 
  generally observed for H3K27 methylation of the promoters we 
have examined (unpublished data). One explanation for this dif-
ference could relate to differences in antibody specifi  city; it is 
possible that the anti–trimethyl H3K9 (“branched”) antibodies 
used in previous experiments also recognized H4K20Me3 and 
H3K27Me3 (Nielsen et al., 2001; Ait-Si-Ali et al., 2004; Sarma 
et al., 2004). In contrast, the anti-H3K27 antibody used in our 
study is specifi  c for di- and trimethylated forms of H3K27 and does 
not bind to other histone residues (Sarma et al., 2004). In addi-
tion, we note that our studies examined pure myotubes rather 
than a mixed population of quiescent/undifferentiated and dif-
ferentiated cells.
Despite numerous attempts to identify the HMTase respon-
sible for silencing pRb targets, we have failed to detect PRC2 
binding (Fig. 5 D and not depicted). Preliminary ChIP-on-chip 
experiments using antibodies against Suz12 have reliably iden-
tifi  ed several fate determination genes silenced by PRC2 (nota-
bly, Hox gene clusters) but did not reveal a clear association 
between PRC2- and pRb-regulated genes. The interaction of PRC2 
with these loci may be outside the range surveyed by our micro-
arrays, be short-lived, or occur at an earlier stage of differentiation. 
However, a most intriguing possibility is that enzymes distinct 
from PRC2 may possess H3K27 HMTase activity and target 
pRb-regulated genes; G9a and Whistle (Tachibana et al., 2001; 
Kim et al., 2006) are candidates. Both enzymes are expressed in 
C2C12 cells (unpublished data) and it is therefore possible that 
they are involved in the trimethylation of H3K27 at pRb-regulated 
genes during myogenic differentiation. It is thought that PRC2 
is responsible for most H3K27 trimethylation in the nucleus 
(Erhardt et al., 2003; Pasini et al., 2004; Schoeftner et al., 2006) 
but, because these observations have been made using low-
resolution techniques at early developmental stages, a role for 
other HMTases cannot currently be ruled out.
It is also not presently known how pRb promotes H3K27 
methylation of its targets. Our limited ChIP analyses have failed to 
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of recent studies of the Cdkn2a gene, which is also silenced by 
H3K27 methylation in a pRb-dependent manner without detect-
able pRb recruitment (Bracken et al., 2007; Kotake et al., 2007). 
It is possible that a pRb complex transiently establishes a spe-
cifi  c chromatin environment at target genes that promotes the 
subsequent methylation of H3K27 by a distinct enzyme. In such 
a scenario, stepwise modifi  cation of histone tail residues could 
occur, with deacetylation of H3Ac representing an early, reversible 
event (Fig. 6 B). H3K27Me3 could constitute an intermediate or 
fi  nal mark, although it appears at genes relatively late in the dif-
ferentiation process (Figs. 3 D and 6 B). The H3K27Me3 mark 
is lost and cell cycle genes are reexpressed upon knockdown of 
pRb, which suggests that there would be constant turnover of these 
histone modifi  cations in the absence of pRb and that one role of 
pRb in the establishment of irreversible cell cycle arrest is to tip 
the scale toward maintenance of this repressive modifi  cation.
In contrast with the aforementioned group of pRb targets, we 
found that Ccnd1 expression was silenced via pRb-independent 
H3K27 trimethylation and PcG complex binding (Fig. 6 B). It is 
worth noting that Ccnd1 is at the core of the cell’s mitogen-sensing 
machinery, as it mediates (with Cdk4) the initial pRb inactiva-
tion steps in late G1 phase (Blagosklonny and Pardee, 2002). 
Permanent silencing of its expression could therefore complement 
the repressive action of pRb on cell cycle effector genes (Fig. 6 B). 
Additional experiments must be performed to determine the mode 
of recruitment of PRC complexes at the Ccnd1 promoter.
Materials and methods
Cell culture
The C2C12 murine myoblast cell line (obtained from the American Type 
Culture Collection) was cultured in growth medium consisting of DME sup-
plemented with 10% fetal bovine serum, 2 mM glutamine, and antibiotics. 
In all experiments, care was taken to harvest myoblasts in proliferation at 
a point well before conﬂ  uence (<60% conﬂ  uence) to avoid cell cycle exit 
and spontaneous differentiation. To induce differentiation, myoblasts were 
grown to conﬂ  uence, rinsed twice with PBS, and grown in differentiation 
medium consisting of DME supplemented with 2% horse serum. To harvest 
myotubes and separate them from the undifferentiated cells (so-called re-
serve cells), the differentiated cultures were harvested using diluted trypsin, 
which results in the selective detachment of myotubes (Blais et al., 2005). 
Primary mouse myoblasts were obtained from the lab of M. Rudnicki 
(Ottawa Health Research Institute, Ottawa, Canada) or prepared as described 
previously (Rando and Blau, 1994). In both cases, the cells were grown on 
Matrigel-coated dishes (Becton Dickinson). Some experiments were also 
repeated using mouse satellite cells isolated from single soleus muscle ﬁ  ber 
cultures as described previously (Rosenblatt et al., 1995). Once enough 
satellites cells had migrated out of the ﬁ  bers, the cultures were trypsinized, 
expanded for one passage, and plated on 8-well slides (Thermo Fisher 
Scientiﬁ  c) coated with Matrigel. After 4–5 d, the cells had started to differenti-
ate and were transferred to differentiation-promoting medium. 1 wk later, 
the resulting primary myotubes were transfected with siRNA duplexes as 
described in RNAi assays. Primary MEFs from mixed backgrounds were 
provided by G. David and B. Grandinetti (New York University School of 
Medicine, New York, NY) and grown in growth medium for a maximum of 
six passages to avoid replicative senescence. For mitogen starvation, they 
were cultured for 3 d in medium devoid of serum.
Antibodies
The MF20 antibody against myosin heavy chain (MHC; Bader et al., 
1982) and the G3G4 antibody against BrdU (George-Weinstein et al., 
1993) were obtained from the Developmental Studies Hybridoma Bank. 
The FITC-coupled anti-BrdU antibody was obtained from Roche. Anti–phos-
pho-Ser10-histone H3 was obtained from Millipore and anti–γ-tubulin and 
–α-tubulin antibodies were obtained from Sigma-Aldrich. The anti–cyclin B1 
monoclonal (GNS1) was a gift of S. Shiff (Robert Wood Johnson University 
Hospital, New Brunswick, NJ). Anti-H3K27Me2/3 (clone 7B11; a gift of 
D. Reinberg, New York University School of Medicine) has been character-
ized previously (Sarma et al., 2004). Anti-H3K27Me2 (ab24684), anti-
H3K27Me3 (ab6002), and anti-H3K9Me3 (ab8898) were obtained from 
Abcam. Anti–pan-acetylated H3 (K9Ac + K14Ac, 06-599) was obtained 
from Millipore. The anti-Bmi1 mAb was provided by K. Helin (Biotech Re-
search and Innovation Center, Copenhagen, Denmark)
Immunoﬂ  uorescence and image acquisition
Cells were plated on slide ﬂ  asks (Thermo Fisher Scientiﬁ  c) and grown and 
differentiated as described in Cell culture. They were ﬁ  xed using formalin 
(Sigma-Aldrich), permeabilized with 1% Triton X-100 in PBS, and blocked 
in PBS containing 3% BSA. Antibodies were diluted in blocking buffer and 
FITC- or Cy3-coupled secondary antibodies were used (Jackson Immuno-
Research Laboratories). For BrdU incorporation, myotubes were pulsed for 
12 h with 10 μM BrdU (Roche) and then processed for immunoﬂ  uorescence. 
After staining with primary antibodies against MHC and secondary Cy3-
coupled anti–mouse antibody, the samples were ﬁ  xed a second time with 
formalin and denatured for 10 min in 4 N HCl. After neutralization, the 
samples were incubated with FITC-coupled anti-BrdU (Roche). After in-
cubation with biotin-labeled anti-BrdU antibodies, the samples were fur-
ther incubated with FITC-labeled streptavidin (Jackson ImmunoResearch 
Laboratories). For H3S10P staining, the cells were ﬁ  rst extracted sequentially 
for 5 min in CSK buffer (100 mM NaCl, 300 mM sucrose, 10 mM piperazine-
N,N′-bis[2-ethane-sulfonic acid], Pipes, pH 6.8, and 3 mM MgCl2) and 
5 min in CSK buffer containing 0.5% Triton X-100 (Martini et al., 1998) be-
fore being ﬁ  xed with formalin as before. All samples were mounted in Pro-
long anti-fade medium (Invitrogen). Photomicrography was performed at 
room temperature using a ﬂ  uorescence microscope (Axiovert 200M; Carl 
Zeiss, Inc.) equipped with a camera (Retiga 2000R; QImaging) and con-
trolled with Metamorph 7.0 software (MDS Analytical Technologies). All 
photomicrographs were taken using 20× Plan Apo 0.75 differential inter-
ference contrast M inﬁ  nity/0.17 WD 1.0 (for most ﬁ  gures) or 100× Plan 
Apo 1.40 oil differential interference contrast H inﬁ  nity/0.17 WD 0.13 
(for Fig. S3) objectives (both obtained from Nikon). For all photographic 
data, images were acquired as 8-bit-per-channel TIF ﬁ  les. In some instances 
where the overall signal was low, intensity levels were adjusted using the 
Levels tool of Photoshop one color channel at a time but gamma adjust-
ments were never made. For gel photographs, all lanes for a given gene/
protein were subjected to identical adjustments so that the band intensities 
can be directly compared. Care was also taken to avoid pixel clipping.
RNAi assays
Cells were grown to conﬂ  uence, induced to differentiate for 4–5 d, and 
transfected with siRNA duplexes (Thermo Fisher Scientiﬁ  c) using the siM-
PORTER reagent (Millipore), according to the manufacturer’s recommenda-
tions. The sequences are listed in Table S2. The amount of RNA transfected 
was kept constant in each transfection experiment. For experiments per-
formed in myoblasts, cells were transfected at 50% conﬂ  uence and induced 
to differentiate for 2 d after they reached conﬂ  uence.
RT-PCR and expression proﬁ  ling
RT-PCR was performed using 250 ng of total RNA per reverse transcriptase 
reaction. 1% of the resulting cDNA was then used as a template for semi-
quantitative PCR. In each case, PCR reactions were determined to be in the 
linear phase of the ampliﬁ  cation. The sequence of the oligonucleotide primers 
used is given in Table S3 (available at http://www.jcb.org/cgi/content/
full/jcb.200705051/DC1) along with the expected size of the amplicons. 
Expression proﬁ  ling with microarrays was performed in triplicate (except 
when noted) as described previously (Blais et al., 2005) using MOE430A 2.0 
chips (Affymetrix). The data were analyzed using the program dChip (Li 
and Hung Wong, 2001) with the PM-MM model and averaging of replicate 
samples. Additional ﬁ  ltering was performed manually, removing micro-
array probes for which the maximum mean value across samples was <75 
and those for which the number of “present” calls among all samples is <2.
ChIP assays
ChIP assays were performed essentially as described previously (Takahashi 
et al., 2000). For histone marks, less chromatin was used per immuno-
precipitation to maintain the antibody in excess. 1 μg chromatin was used 
for H3, H3Ac, and H3K27Me2. 7.5 μg chromatin was used for H3K27Me3. 
In some cases, real-time PCR quantitation (qChIP) of the immunoprecipitated 
material was performed using the SYBR green method. The value obtained 
with a nonspeciﬁ  c antibody (normal rabbit IgG) was subtracted from the 
value obtained with the test antibodies and the overall efﬁ  ciency was ex-
pressed as a fraction of the material used in the ChIP reaction. Values were PRB AND IRREVERSIBLE CELL CYCLE ARREST • BLAIS ET AL. 1411
adjusted to zero when the ChIP signal was lower than that obtained with 
the irrelevant antibody control. The raw numerical data is presented in Table S2 
and the sequences of the oligos used are listed in Table S3. ChIP assays on 
primary myoblasts and myotubes were done similarly using two sources of 
primary myoblasts: with fresh cultures prepared according to a previously 
published method (Rando and Blau, 1994) and with cultures obtained from 
the lab of M. Rudnicki. In both cases, chromatin was prepared from myoblasts 
and myotubes and duplicate ChIP assays were performed for each sample 
for a total of four ChIP assays. The signal of H3K27Me2/3 was then quan-
titated using real-time PCR.
ChIP-on-chip experiments
A mouse proximal promoter microarray was used to identify the target 
genes of E2F4 and p130 in C2C12 myotubes using ChIP-on-chip (Blais 
et al., 2005). The antibodies used were rabbit anti-E2F4 (Santa Cruz Bio-
technology, Inc.) and mouse anti-p130 (Becton Dickinson).
Online supplemental material
Fig. S1 shows the expression proﬁ  les of pocket proteins during C2C12 dif-
ferentiation. It also demonstrates the failure of myogenesis and improper 
cell cycle exit in the absence of pRb. Fig. S2 demonstrates that distinct 
siRNA duplexes targeting the pocket proteins generate essentially the same 
effect at the level of target gene expression. Fig. S3 documents mitotic en-
try after the knockdown of pRb together with either p107 or p130 and 
suggests the existence of a G2/M checkpoint in which these proteins 
participate. Fig. S4 further demonstrates that two distinct pRb-targeting siRNA 
duplexes generate essentially the same effect at the level of gene ex-
pression. Fig. S5 shows the di- and trimethylation of H3K27 of additional 
genes silenced during differentiation in a pRb-dependent and -independent 
manners. It also demonstrates the expression proﬁ  le of the Ezh2 HMTase 
during C2C12 differentiation. Table S1 represents the summary of our ex-
pression proﬁ  ling data. Table S2 gives the raw quantitative ChIP data rep-
resented in the main text. Table S3 gives the sequence of all DNA and RNA 
oligonucleotides used in this paper. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200705051/DC1.
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